Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL20581252

COc1cc2c(cc1OCCCN1CCCC1)[nH]c1cc(CO)ncc12.O=C(O)C(F)(F)F

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EHMT2 Q96KQ7 13/20 0.47
▸ EHMT1 Q9H9B1 11/20 0.47
▸ KDM4E B2RXH2 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.45
▸ SPIN1 Q9Y657 2/20 0.44
▸ PLK4 O00444 1/20 0.41
▸ GAK O14976 1/20 0.41
▸ EPHB6 O15197 1/20 0.41
▸ RIPK2 O43353 1/20 0.41
▸ ERN1 O75460 1/20 0.41
▸ STK10 O94804 1/20 0.41
▸ MAP4K4 O95819 1/20 0.41
▸ CHEK2 O96017 1/20 0.41
▸ ABL1 P00519 1/20 0.41
▸ EGFR P00533 1/20 0.41
▸ ERBB2 P04626 1/20 0.41
▸ LCK P06239 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23784349 0.92 EHMT2 (0.49) EHMT2EHMT1KDM4EALDH1A1ALOX15
SCHEMBL20581253 0.87 EHMT2 (0.45) EHMT2EHMT1KDM4EALDH1A1ALOX15
SCHEMBL23784378 0.80 EHMT2 (0.51) EHMT2EHMT1KDM4EALDH1A1ALOX15
Trifluoroacetic Acid SCHEMBL20580800 0.80 EHMT2 (0.51) EHMT2EHMT1KDM4EALDH1A1ALOX15
SCHEMBL23784367 0.79 EHMT2 (0.52) EHMT2EHMT1KDM4EALDH1A1ALOX15
SCHEMBL20581138 0.78 EHMT2 (0.56) EHMT2EHMT1KDM4EALDH1A1ALOX15
Hydrochloric Acid SCHEMBL20581101 0.78 EHMT2 (0.51) EHMT2EHMT1KDM4EALDH1A1ALOX15
Formic Acid SCHEMBL20580538 0.78 KDM4E (0.49) EHMT2EHMT1KDM4EALDH1A1ALOX15
Hydrochloric Acid SCHEMBL20581141 0.77 EHMT2 (0.55) EHMT2EHMT1KDM4EALDH1A1ALOX15
SCHEMBL20580539 0.76 SPIN1 (0.48) EHMT2EHMT1KDM4EALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3634962-B1 AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS GLOBAL BLOOD THERAPEUTICS INC (US) 2023-05-24 — — EP disclosed
US-20210371417-A1 AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. 2021-12-02 — — US disclosed
US-11111243-B2 Azaindole compounds as histone methyltransferase inhibitors GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-09-07 — — US disclosed
CN-110997671-A Azaindole compounds as histone methyltransferase inhibitors 全球血液疗法股份有限公司 2020-04-10 — — CN disclosed
US-20180354947-A1 AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. 2018-12-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11111243-B2 Azaindole compounds as histone methyltransferase inhibitors EHMT2, EHMT1, EZH2 EHMT2 1/4885EHMT1 2/4885KDM4E 73/4885
US-20210371417-A1 AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS EHMT2, EHMT1, EZH2 EHMT2 1/4885EHMT1 2/4885KDM4E 73/4885
US-20180354947-A1 AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS EHMT2, EHMT1, EZH2 EHMT2 1/4885EHMT1 2/4885KDM4E 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback